×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PFE – pfizer, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PFE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/21
12:27 pm
pfe
Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026 [Yahoo! Finance]
Low
Report
Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026 [Yahoo! Finance]
4/21
11:51 am
pfe
Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026
Low
Report
Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026
4/20
06:03 pm
pfe
CICC Initiates Coverage of Pfizer Inc. (PFE) With an Outperform Rating [Yahoo! Finance]
Low
Report
CICC Initiates Coverage of Pfizer Inc. (PFE) With an Outperform Rating [Yahoo! Finance]
4/20
03:17 pm
pfe
Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says [Yahoo! Finance Canada]
Low
Report
Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says [Yahoo! Finance Canada]
4/20
03:13 pm
pfe
Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says [Yahoo! Finance]
Low
Report
Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says [Yahoo! Finance]
4/20
01:42 pm
pfe
After her cancer misdiagnosis, Lucy Liu advocates for early screening [USA TODAY]
Low
Report
After her cancer misdiagnosis, Lucy Liu advocates for early screening [USA TODAY]
4/20
09:54 am
pfe
Pfizer (PFE) had its "underperform" rating reaffirmed by Royal Bank Of Canada. They now have a $25.00 price target on the stock.
Low
Report
Pfizer (PFE) had its "underperform" rating reaffirmed by Royal Bank Of Canada. They now have a $25.00 price target on the stock.
4/20
07:06 am
pfe
U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility [Yahoo! Finance]
Low
Report
U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/17
01:16 pm
pfe
Form 4 PFIZER INC For: Apr 15 Filed by: BOURLA ALBERT
Low
Report
Form 4 PFIZER INC For: Apr 15 Filed by: BOURLA ALBERT
4/16
04:31 pm
pfe
Form 4 PFIZER INC For: Apr 14 Filed by: BOURLA ALBERT
Low
Report
Form 4 PFIZER INC For: Apr 14 Filed by: BOURLA ALBERT
4/10
01:11 pm
pfe
Form 3 PFIZER INC For: Apr 01 Filed by: Hancock Dennis P
Low
Report
Form 3 PFIZER INC For: Apr 01 Filed by: Hancock Dennis P
4/1
05:53 pm
pfe
Form 4 PFIZER INC For: Mar 31 Filed by: BOURLA ALBERT
Low
Report
Form 4 PFIZER INC For: Mar 31 Filed by: BOURLA ALBERT
3/30
08:22 pm
pfe
Form 4 PFIZER INC For: Mar 27 Filed by: Taraporevala Cyrus
Low
Report
Form 4 PFIZER INC For: Mar 27 Filed by: Taraporevala Cyrus
3/30
08:21 pm
pfe
Form 4 PFIZER INC For: Mar 27 Filed by: SMITH JAMES C
Low
Report
Form 4 PFIZER INC For: Mar 27 Filed by: SMITH JAMES C
3/30
08:20 pm
pfe
Form 4 PFIZER INC For: Mar 27 Filed by: Quincey James
Low
Report
Form 4 PFIZER INC For: Mar 27 Filed by: Quincey James
3/30
08:19 pm
pfe
Form 4 PFIZER INC For: Mar 27 Filed by: Echevarria Joseph
Low
Report
Form 4 PFIZER INC For: Mar 27 Filed by: Echevarria Joseph
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/12
How to invest when the coronavirus pandemic and Trump send the Dow crashing: experts [Yahoo! Finance News]
10.1%
3/26 Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn 7.6%
3/16 Form 4 PFIZER INC For: Mar 13 Filed by: YOUNG JOHN D 6.3%
3/27 Form 8-K PFIZER INC For: Mar 25 5.8%
3/4 Europe 'panicking' over India's pharmaceutical export curbs - industry group [Reuters] 5.3%
2/28 Form 4 PFIZER INC For: Feb 26 Filed by: LANKLER DOUGLAS M 4.4%
4/1 Medical Professionals Across Merck & Co., Inc., Pfizer Inc., and Eli Lilly and Company Activate to Support Health Systems, First Responders and Patients Amid COVID-19 Pandemic 3.5%
3/9 Form 3 PFIZER INC For: Mar 01 Filed by: DAMICO JENNIFER B. 3.2%
3/17 Coronavirus Spreads To All 50 States As 1st Case Reported In West Virginia; NYPD Officer Tests Positive [zero hedge] 3.1%
4/9 Pfizer says early studies of potential coronavirus treatment show promise [Reuters] 2.8%
3/26 Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn 7.6%
3/16 Form 4 PFIZER INC For: Mar 13 Filed by: YOUNG JOHN D 6.3%
3/27 Form 8-K PFIZER INC For: Mar 25 5.8%
3/4 Europe 'panicking' over India's pharmaceutical export curbs - industry group [Reuters] 5.3%
2/28 Form 4 PFIZER INC For: Feb 26 Filed by: LANKLER DOUGLAS M 4.4%
4/1 Medical Professionals Across Merck & Co., Inc., Pfizer Inc., and Eli Lilly and Company Activate to Support Health Systems, First Responders and Patients Amid COVID-19 Pandemic 3.5%
3/9 Form 3 PFIZER INC For: Mar 01 Filed by: DAMICO JENNIFER B. 3.2%
3/17 Coronavirus Spreads To All 50 States As 1st Case Reported In West Virginia; NYPD Officer Tests Positive [zero hedge] 3.1%
4/9 Pfizer says early studies of potential coronavirus treatment show promise [Reuters] 2.8%
TOP News Decliners
8/8
Form 10-Q PFIZER INC For: Jun 30
-15.1%
3/13 A 5-point plan for pharmaceutical companies [MSNBC.com] -8.1%
7/29 How Big Is Pfizer's Generic Drugs Business That It Plans To Merge With Mylan? [Forbes] -6.5%
3/10 Zentalis Pharmaceuticals Seeks Development Funding From IPO [Seeking Alpha] -6.5%
3/20 ViiV Healthcare Announces First Global Regulatory Approval of CABENUVA; the First Complete, Long-acting, Regimen for the Treatment of HIV -6.4%
3/18 Pfizer Announces Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults Aged 18 Years or Older -6.2%
7/29 M&A deals make major headlines [Seeking Alpha] -5.8%
1/28 Q4/2019 12/31/2019 EPS 0.550 ZacksConsensus 0.570 ActVsEst (0.020) - Miss -5.5%
3/6 Iran Hawks Pressuring White House To Halt 'Humanitarian' Medicine To Iran Amid Outbreak [zero hedge] -4.8%
4/28 US STOCKS-Wall St set to jump as 3M, Pfizer earnings impress [Reuters] -3.4%
3/13 A 5-point plan for pharmaceutical companies [MSNBC.com] -8.1%
7/29 How Big Is Pfizer's Generic Drugs Business That It Plans To Merge With Mylan? [Forbes] -6.5%
3/10 Zentalis Pharmaceuticals Seeks Development Funding From IPO [Seeking Alpha] -6.5%
3/20 ViiV Healthcare Announces First Global Regulatory Approval of CABENUVA; the First Complete, Long-acting, Regimen for the Treatment of HIV -6.4%
3/18 Pfizer Announces Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults Aged 18 Years or Older -6.2%
7/29 M&A deals make major headlines [Seeking Alpha] -5.8%
1/28 Q4/2019 12/31/2019 EPS 0.550 ZacksConsensus 0.570 ActVsEst (0.020) - Miss -5.5%
3/6 Iran Hawks Pressuring White House To Halt 'Humanitarian' Medicine To Iran Amid Outbreak [zero hedge] -4.8%
4/28 US STOCKS-Wall St set to jump as 3M, Pfizer earnings impress [Reuters] -3.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: